Author: Kate Smith

Three Human Cases of West Nile Virus Identified in New Castle County

Posted on by

DOVER, DE (Sept. 12, 2023) – The Delaware Public Health Laboratory (DPHL) has identified this year’s first human cases of West Nile Virus (WNV) in three men 50 years of age and older, all of whom reside in New Castle County. All three individuals who contracted WNV were hospitalized due to infection from the mosquito-borne illness. At this time, it appears that each WNV victim is likely to have contracted the disease locally, but a public health investigation is ongoing, the Delaware Division of Public Health (DPH) announced today. Read more

Posted in PR

FDA Approves Updated COVID-19 Vaccines

Posted on by

Yesterday, the U.S. Food and Drug Administration took action approving and authorizing for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death. Today’s actions relate to updated mRNA vaccines for 2023-2024 manufactured by ModernaTX Inc. and Pfizer Inc. Read More

FDA Approves Maternal RSV Vaccine

Posted on by

August 21, 2023. Fenit Nirappil, Washington Post Federal regulators on Monday approved a maternal RSV vaccine administered during pregnancy to protect infants from severe illness. It’s the latest in a new arsenal of immunizations against the common respiratory virus that is the leading cause of hospitalization in young children and kills thousands of seniors annually. Read more.

ACIP Votes Unanimously to Recommend Nirsevimab

Posted on by

Today, ACIP voted unanimously (10 YES – 0 NO for all votes) to recommend nirsevimab for use in infants <8 months born or entering their first RSV season, and for children aged 8-19 months who are at increased risk of RSV disease entering their second RSV season (agenda and slides). The Committee also voted for the inclusion of nirsevimab in VFC: Infants aged <8 months born during or entering their first RSV reason are recommended to receive one dose of nirsevimab (50 mg for infants <5 kg and 100 mg for infants ≥5kg) Children aged 8-19 months who are at Read More …

August is National Immunization Awareness Month!

Posted on by

National Immunization Awareness Month (NIAM) is an annual observance held in August to highlight the importance of routine vaccination for people of all ages. Use these resources to help you discuss routine vaccinations with your patients and parents during NIAM and throughout the year. Check out the toolkit here!

Improving the Vaccine Experience

Posted on by

Free, 1-hour webinar hosted by ImmunizeOrg, “Improving the Vaccination Experience: Reducing Pain and Anxiety for Children and Adults” at 1 p.m. ET on Feb 28. Anxiety about needles and injections affects as many as 2 out of 3 children and 1 out of 4 adults; this anxiety can contribute to dreading, delaying, or avoiding vaccinations, even when the importance of preventing illness is understood. The good news is that there are safe, effective, and practical steps that those who administer vaccines and vaccine recipients or their caregivers can take to reduce vaccination-related pain and anxiety and increase confidence in vaccination. Read More …

DPH Announces Start of Flu Season

Posted on by

DOVER, DE (Sept. 29, 2022) – October 2 marks the official start of the 2022-2023 influenza (flu) season. The flu vaccine plays a pivotal role in helping to avoid significant flu-related illnesses, including hospitalization and death. The Delaware Division of Public Health (DPH) believes it is vital for Delawareans to protect themselves and their loved ones by getting the flu vaccine as soon as possible, particularly given the ongoing battle against COVID-19 and a potentially active flu season ahead. The U.S. often looks to the experience of Australia and New Zealand in the Southern Hemisphere during their flu season in the summer as a possible Read More …

Monkeypox Vaccine

Posted on by

New data in JAMA report that 90 people who received monkeypox vaccine — Jynneos, made by Bavarian Nordic — through their clinics from late June to September contracted the virus. Most of those people (77%) tested positive in the first 14 days after their first dose, a time during which their immune responses to the vaccine were still developing. But 21 people contracted the virus after 14 days, eight after 28 days, and two contracted monkeypox three weeks or more after receiving both doses of the vaccine. During the study period, 7,339 people received a first dose at the clinics.  Read More …

Eligibility for Monkeypox Vaccine Expands in Delaware

Posted on by

DOVER, DE (Sept 22, 2022) ­– The Delaware Division of Public Health (DPH) is sharing upcoming opportunities for individuals to get vaccinated against the monkeypox virus (MPX). The current case count for MPX in the state is 35, including 23 cases in New Castle County, three cases in Kent County, and nine cases in Sussex County. Delaware continues to offer vaccinations to people at a higher risk of exposure. Vaccine eligibility is being expanded to include all gay, bisexual and transgender or nonbinary persons having sex with men, or females having sex with gay, bisexual, non-binary, or transgender males. Delaware is also expanding vaccine eligibility to health care workers Read More …